UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Pseudoephedrine-containing drugs could cause acute skin reaction’
The government is likely to add a warning in the instructions of pseudoephe...
by Lee Hye-seon
|
2019-01-31 14:34
라인
₩4.7 billion spent on compensation for side effect injuries in 4 years
Korea used 4.74 billion won ($4.24 million) to compensate the damages such ...
by Lee Hye-seon
|
2019-01-30 17:18
라인
Government to tighten rule for drug license renewal
The government will not allow renewal of drug approval if a company manufac...
by Lee Hye-seon
|
2019-01-29 12:51
라인
Korea to set up new review process for advanced medical devices
The Ministry of Food and Drug Safety said it would enhance drug safety mana...
by Lee Hye-seon
|
2019-01-28 17:35
라인
4 local firms win exclusive rights to sell Pradaxa’s generic copies
The Supreme Court recently ruled that drugmakers’ alteration of an original...
by Lee Hye-seon
|
2019-01-28 11:56
라인
Two CROs reprimanded for delayed reports of adverse events
The Ministry of Food and Drug Safety issued a warning to two clinical resea...
by Lee Hye-seon
|
2019-01-24 15:40
라인
Court rejects patent registration for acute myeloid leukemia drug Vyxeos
The Patent Court of Korea has rejected Jazz Pharmaceuticals’ application fo...
by Lee Hye-seon
|
2019-01-23 14:47
라인
New HIV combo pill Biktarvy approved in Korea
Gilead Sciences said it has obtained approval for Biktarvy, a three-in-one ...
by Lee Hye-seon
|
2019-01-21 15:36
라인
‘Pharmaceuticals need President Moon’s committed support’
The chief of Korea’s representative biopharmaceutical industry group called...
by Lee Hye-seon
|
2019-01-17 17:39
라인
Intra-articular injection Conjuran recognized as new medical tech
The government recognized Pharma Research Products’ intra-articular injecti...
by Lee Hye-seon
|
2019-01-15 14:07
라인
Baxter’s dialyzer suspended due to bad-mouthing rival products
The government ordered Baxter to suspend the sale of Theranova, a blood fil...
by Lee Hye-seon
|
2019-01-15 11:42
라인
5 pharmaceuticals win nod for sustained-release neuropathic pain reliever
Five local drugmakers have obtained approval for medicines that changed the...
by Lee Hye-seon
|
2019-01-14 14:56
라인
14 drugmakers to release generic copies of Stillen 2X in early February
Fourteen pharmaceutical companies are likely to roll out generic drugs that...
by Lee Hye-seon
|
2019-01-14 11:34
라인
Dongkoo to test stem cell therapy for diabetic foot ulcers
Dongkoo Bio & Pharma said it would conduct a clinical trial to expand the t...
by Lee Hye-seon
|
2019-01-11 15:53
라인
MSD Korea recalls HIV drug Stocrin with particular code
MSD Korea said it would recall HIV treatment Stocrin (ingredient: efavirenz...
by Lee Hye-seon
|
2019-01-10 11:46
라인
Regulator keeps Kyung Nam Pharm listed with 1-year grace period
The Korean stock market operator decided to keep Kyung Nam Pharm listed on ...
by Lee Hye-seon
|
2019-01-09 14:49
라인
Handok and Genexine become largest stakeholder of Rezolute
Korean pharmaceuticals Handok and Genexine said they have jointly become th...
by Lee Hye-seon
|
2019-01-08 14:53
라인
New influenza drug to be tested in phase-3 trial in Korea
The Korean government has approved a phase-3 clinical trial to evaluate the...
by Lee Hye-seon
|
2019-01-07 15:30
라인
Regulator to nix approval for Lou Gehrig's drug Yoos Neurosolution
The Korean drug regulator is likely to nullify approval for Yoos Neurosolut...
by Lee Hye-seon
|
2019-01-07 12:46
라인
5 pharmaceuticals’ growth strategies for 2019
Five major local drugmakers celebrated the first working day of 2019 on Wed...
by Lee Hye-seon
|
2019-01-02 16:25
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top